← Open Payments lookup

TAMMY ULEBERG: Open Payments

NPI 1710051628 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$439 in 20 payments from 9 companies in 2025. Trend: 2023 $248 · 2024 $347 · 2025 $439

Food & beverage: $439
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$110
Axsome Therapeutics, Inc.4$105
Alkermes, Inc.3$60
Otsuka America Pharmaceutical, Inc.2$36
Neurocrine BioSciences, Inc.2$33
E.R. Squibb & Sons, L.L.C.1$30
Collegium Pharmaceutical, Inc.1$24
Teva Pharmaceuticals USA, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: CAPLYTA, Auvelity, ARISTADA, REXULTI, INGREZZA, COBENFY, Jornay PM, AUSTEDO XR.

Industry payments across ND — which companies pay providers there.